Global Molecular Imaging Agents Market is expected to grow at a CAGR of 7.2% during the forecast period, to reach USD 3.5 billion by 2030 from USD 2.4 billion in 2018. The market is driven by factors such as increasing prevalence of chronic diseases and rising demand for minimally invasive procedures, which are driving the growth of molecular imaging agents market globally.
The global molecular imaging agents market is segmented on the basis of type into small molecules, peptides, engineered protein fragments, aptamers and nanoparticles; on the basis of application into oncology, cardiology, gastrointestinal disorders and neurology disorders; and on the basis of region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA).
North America accounted for a major share in global molecular imaging agents market due to high adoption rate among patients with cancerous tumors in this region. The US, Canada and Mexico are some major countries contributing to this regional share followed by Europe with its high adoption rate among patients with cancerous tumors as well as other chronic diseases such as cardiovascular disease or neurological disorder like Alzheimer’s disease or Parkinson’s disease which are driving up demand for molecular imaging agents in this region.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of cancer and other diseases is driving the growth of molecular imaging agents market.
- The increasing number of research and development activities in the field of molecular imaging agents is also driving the growth of this market.
- The growing demand for minimally invasive procedures is also a major factor that drives the growth of this market.
- Increasing government funding for research and development activities in molecular imaging agents is another factor that drives the growth of this market.
- Increasing awareness about molecular imaging agents among physicians, patients, and healthcare providers are some other factors that drive the growth of this market.
Industry Growth Insights published a new data on “Molecular Imaging Agents Market”. The research report is titled “Molecular Imaging Agents Market research by Types (Small Molecules, Peptides, Engineered Protein Fragments, Aptamers, Nanoparticles, Others), By Applications (Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders, Others), By Players/Companies General Electric, Bracco Diagnostic, Eisai, Guerbet”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Molecular Imaging Agents Market Research Report
By Type
Small Molecules, Peptides, Engineered Protein Fragments, Aptamers, Nanoparticles, Others
By Application
Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders, Others
By Companies
General Electric, Bracco Diagnostic, Eisai, Guerbet
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Molecular Imaging Agents Market Report Segments:
The global Molecular Imaging Agents market is segmented on the basis of:
Types
Small Molecules, Peptides, Engineered Protein Fragments, Aptamers, Nanoparticles, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- General Electric
- Bracco Diagnostic
- Eisai
- Guerbet
Highlights of The Molecular Imaging Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Small Molecules
- Peptides
- Engineered Protein Fragments
- Aptamers
- Nanoparticles
- Others
- By Application:
- Oncology
- Cardiology
- Gastrointestinal Disorders
- Neurology Disorders
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Molecular Imaging Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Molecular imaging agents are molecules that can be used to image the structure of biological molecules. These agents can be used to visualize proteins, DNA, and other biomolecules in situ.
Some of the major companies in the molecular imaging agents market are General Electric, Bracco Diagnostic, Eisai, Guerbet.
The molecular imaging agents market is expected to register a CAGR of 7.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Molecular Imaging Agents Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Molecular Imaging Agents Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Molecular Imaging Agents Market - Supply Chain
4.5. Global Molecular Imaging Agents Market Forecast
4.5.1. Molecular Imaging Agents Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Molecular Imaging Agents Market Size (000 Units) and Y-o-Y Growth
4.5.3. Molecular Imaging Agents Market Absolute $ Opportunity
5. Global Molecular Imaging Agents Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Molecular Imaging Agents Market Size and Volume Forecast by Type
5.3.1. Small Molecules
5.3.2. Peptides
5.3.3. Engineered Protein Fragments
5.3.4. Aptamers
5.3.5. Nanoparticles
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Molecular Imaging Agents Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Molecular Imaging Agents Market Size and Volume Forecast by Application
6.3.1. Oncology
6.3.2. Cardiology
6.3.3. Gastrointestinal Disorders
6.3.4. Neurology Disorders
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Molecular Imaging Agents Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Molecular Imaging Agents Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Molecular Imaging Agents Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Molecular Imaging Agents Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Molecular Imaging Agents Demand Share Forecast, 2019-2026
9. North America Molecular Imaging Agents Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Molecular Imaging Agents Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Molecular Imaging Agents Market Size and Volume Forecast by Application
9.4.1. Oncology
9.4.2. Cardiology
9.4.3. Gastrointestinal Disorders
9.4.4. Neurology Disorders
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Molecular Imaging Agents Market Size and Volume Forecast by Type
9.7.1. Small Molecules
9.7.2. Peptides
9.7.3. Engineered Protein Fragments
9.7.4. Aptamers
9.7.5. Nanoparticles
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Molecular Imaging Agents Demand Share Forecast, 2019-2026
10. Latin America Molecular Imaging Agents Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Molecular Imaging Agents Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Molecular Imaging Agents Market Size and Volume Forecast by Application
10.4.1. Oncology
10.4.2. Cardiology
10.4.3. Gastrointestinal Disorders
10.4.4. Neurology Disorders
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Molecular Imaging Agents Market Size and Volume Forecast by Type
10.7.1. Small Molecules
10.7.2. Peptides
10.7.3. Engineered Protein Fragments
10.7.4. Aptamers
10.7.5. Nanoparticles
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Molecular Imaging Agents Demand Share Forecast, 2019-2026
11. Europe Molecular Imaging Agents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Molecular Imaging Agents Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Molecular Imaging Agents Market Size and Volume Forecast by Application
11.4.1. Oncology
11.4.2. Cardiology
11.4.3. Gastrointestinal Disorders
11.4.4. Neurology Disorders
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Molecular Imaging Agents Market Size and Volume Forecast by Type
11.7.1. Small Molecules
11.7.2. Peptides
11.7.3. Engineered Protein Fragments
11.7.4. Aptamers
11.7.5. Nanoparticles
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Molecular Imaging Agents Demand Share, 2019-2026
12. Asia Pacific Molecular Imaging Agents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Molecular Imaging Agents Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Molecular Imaging Agents Market Size and Volume Forecast by Application
12.4.1. Oncology
12.4.2. Cardiology
12.4.3. Gastrointestinal Disorders
12.4.4. Neurology Disorders
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Molecular Imaging Agents Market Size and Volume Forecast by Type
12.7.1. Small Molecules
12.7.2. Peptides
12.7.3. Engineered Protein Fragments
12.7.4. Aptamers
12.7.5. Nanoparticles
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Molecular Imaging Agents Demand Share, 2019-2026
13. Middle East & Africa Molecular Imaging Agents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Molecular Imaging Agents Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Molecular Imaging Agents Market Size and Volume Forecast by Application
13.4.1. Oncology
13.4.2. Cardiology
13.4.3. Gastrointestinal Disorders
13.4.4. Neurology Disorders
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Molecular Imaging Agents Market Size and Volume Forecast by Type
13.7.1. Small Molecules
13.7.2. Peptides
13.7.3. Engineered Protein Fragments
13.7.4. Aptamers
13.7.5. Nanoparticles
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Molecular Imaging Agents Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Molecular Imaging Agents Market: Market Share Analysis
14.2. Molecular Imaging Agents Distributors and Customers
14.3. Molecular Imaging Agents Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. General Electric
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bracco Diagnostic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eisai
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Guerbet
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
